Crowdonomics
WatchlistPortfolio
MedVector

Reg CF · Convertible Note · May 2024

ClosedReached targetReg CFConvertible Note
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$114.6K / $618K max
19% of ceiling · target hit day 4
Investors
60
$2.1K avg
Valuation cap
$25M
cap, not an agreed valuation

Raised over time

Cumulative raised
$126K$63K$0
May 19, 2024 · openedOct 21, 2024 · last reading
Target ($15K) hit — May 23, 2024, day 4Deadline Apr 30, 2026 — 556 days out

Left axis: cumulative dollars raised. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$654K
FY2022
$0
−$705K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$653,737
-$704,633
Taxes paid
$0
$0
Balance sheet
Cash
$424,287
$64,386
Accounts receivable
$0
$0
Total assets
$759,063
$411,528
Short-term debt
$360,140
$392,239
Long-term debt
$1,085,000
$0
Total liabilities
$1,445,140
$392,239
Other
Headcount
0
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$25M
Conversion discount12%
Interest rate4.8%

Perks

Invest $500 within the first two weeks and receive 10% bonus interest · until Jun 1, 202410% bonus$500+

Offering details

Target$15,000
Max$618,000
Min investment$500
OpenedMay 19, 2024
DeadlineApr 30, 2026
ClosedOct 21, 2024
Days active155

Links & provenance

Campaign pagePitch videoSEC filing
Source: Manual
0001665160-24-000884
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.